F16.91 Billable / specific Hallucinogen use, unspecified, in remission

ICD-10-CM F16.91 identifies “Hallucinogen use, unspecified, in remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 5: Mental, Behavioral and Neurodevelopmental disorders

Code-level instructions

No additional notes.

Inherited instructions

Chapters 5 · Mental, Behavioral and Neurodevelopmental disorders (F01-F99)

Includes1

disorders of psychological development

Excludes 21

symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)

F16 · Hallucinogen related disorders

Includes3
  • ecstasy
  • PCP
  • phencyclidine

F16.9 · Hallucinogen use, unspecified

Excludes 12
  • hallucinogen abuse (F16.1-)
  • hallucinogen dependence (F16.2-)
Official index references

Official index references (1)

Use(of) (1)

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2022-10-01

Previous assignment: F16.90

History

Code history

Latest recorded change · FY2023

ChangedUnchanged
FY2023

Effective from

  • Added

Hallucinogen use, unspecified, in remission

Billable diagnosis code

CDC/NCHS · FY2023

All editions (9)

All editionsEffective fromCode history
FY20232022-10-01Added
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.